Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Journal of Pharmacokinetics and Pharmacodynamics|October 21, 2023
Learning pharmacometric covariate model structures with symbolic regression networksYlva Wahlquist, Jesper Sundell, Kristian SolteszCPT: Pharmacometrics & Systems Pharmacology|March 10, 2026
Learning Covariate Relations in Disease Progression Models Using Symbolic Neural NetworksJesper Sundell, Ylva Wahlquist, Maria C Kjellsson, et al.Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|October 6, 2020
Individualized closed-loop anesthesia through patient model partitioningYlva Wahlquist, Klaske van Heusden, Guy A Dumont, et al.Cardiovascular Engineering and Technology|April 30, 2021
Prevention of Ischemic Myocardial Contracture Through Hemodynamically Controlled DCDYlva Wahlquist, Kristian Soltesz, Qiuming Liao, et al.Methods in Molecular Biology (Clifton, N.J.)|April 27, 2024
Ex Vivo Working Porcine Heart ModelHenry Pigot, Kristian Soltesz, Stig SteenThe Journal of Antimicrobial Chemotherapy|August 21, 2025
Rifampicin concentrations throughout the entire treatment duration of active tuberculosis; impact of sex and body mass indexTeres Samuelsson, Elisabet Lönnermark, Jesper Sundell, et al.The Journal of Antimicrobial Chemotherapy|August 2, 2021
Effect of efavirenz-based ART on the pharmacokinetics of rifampicin and its primary metabolite in patients coinfected with TB and HIVJesper Sundell, Emile Bienvenu, Angela Äbelö, et al.Ifac-Papersonline|April 15, 2024
Identifiability issues in estimating the impact of interventions on Covid-19 spreadFredrik Gustafsson, Joakim Jaldén, Bo Bernhardsson, et al.Diving and Hyperbaric Medicine|June 15, 2026
Measuring whole-body inert gas uptake and washout during submersionOscar Plogmark, Kristian Soltesz, Carl Hjelte, et al.Antimicrobial Agents and Chemotherapy|September 7, 2022
Effects of Enzyme Induction and Polymorphism on the Pharmacokinetics of Isoniazid and Rifampin in Tuberculosis/HIV PatientsJesper Sundell, Emile Bienvenu, Sofia Birgersson, et al.Pageof 3